Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 986911Generated: October 29, 2026

Dimethylformamide → HCID 22311913, compound

https://huagongshe.com/reaction/986911

Reaction equation

Participants

RoleNameHCIDCharge
ReactantDimethylformamideHCID 6228—
ReactantSodium hydrideHCID 24758—
Reactant1-(2-Chloroethyl)pyrrolidineHCID 81669—
ReactantAntimycin A3aHCID 10052394—
ProductHCID 22311913HCID 22311913—

Reaction Steps

As a typical example of this convergent solution-phase method, Compound 1 may be synthesized as described in Scheme AA. Thus, treatment of 5-nitrobenzimidazolone AAI with 2,6-diCl-Bn-Br in the presence of NaH in DMF afforded two regioisomers AA2a and AA3a (ca. 1:1 ratio), which were then separated by flash column. A small amount of bis-alkylated product was also obtained. The isolated AA3a was further alkylated with 2-chloroethylpyrrolidine by using NaH as a base in DMF to give the di-alkylated product, which was then subjected to nitro reduction with Me2NNH2/FeCl3 to provide aminobenzimidazolone intermediate AA4. Coupling of N-α-Fmoc-N-γ-Boc-diaminobutyric acid (AA5) with benzyl amine in the presence of DCC and HOBt was followed by de-protection of the Fmoc group with diethylamine. The resulting intermediate was coupled with Fmoc-3,4-diF-Phe-OH using DIC/HOBt and treated with diethylamine to give dipeptide amine AA6. Urea formation between the dipeptide amine AA6 and aminobenzimidazolone intermediate AA4 in the presence of 4-nitrophenylchloroformate was followed by de-protection of the Boc group with TFA to afford the target compound 1.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06630451B1
Source datasetuspto-grants-2003_10
ORD IDord-e29edc39a0044b43bf408e7d6cad9fc8
Source noteuspto-grants-2003_10